IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity
Indoleamine 2,3-dioxygenase 2 (IDO2), a homolog of the better-studied tryptophan-catabolizing enzyme IDO1, is an immunomodulatory molecule with potential effects on various diseases including cancer and autoimmunity. Here, we review what is known about the direct connections between IDO2 and immune...
Saved in:
Main Authors: | Lauren M.F. Merlo (Author), Laura Mandik-Nayak (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity
by: Lauren M.F. Merlo, et al.
Published: (2016) -
B-Cell-Targeted 3DNA Nanotherapy Against Indoleamine 2,3-Dioxygenase 2 (IDO2) Ameliorates Autoimmune Arthritis in a Preclinical Model
by: Lauren MF Merlo, et al.
Published: (2020) -
Inflammatory Mediators in Autoimmunity and Systemic Autoimmune Diseases
by: Britt Nakken, et al.
Published: (2015) -
IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma
by: Zikang Xing, et al.
Published: (2024) -
Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses
by: Rachel Ettinger, et al.
Published: (2017)